This site is intended for health professionals only
Wednesday 21 November 2018
Share |

Topic: *** Editor's Pick

November 19, 2018
NHS trusts face staff shortage of more than 350,000 by 2030, think tanks warn

The NHS could have more than 350,000 vacancies by 2030 if emerging workforce trends continue, three healthcare think tanks have said.
 
The health care workforce in England: make or break?, jointly published today by The King’s Fund, the Health Foundation and the Nuffield Trust suggested that under present models of staffing there will be as many as 250,000 vacant NHS posts by 2030, rising from the current 100,000.
 

November 15, 2018
The closer the UK gets to leaving the EU, the more questions that remain unanswered

It has been over two years since 52% of UK voters decided that the country was better off leaving the European Union than staying in. Despite this, it sometimes feels as though no one is any closer to providing answers as to what Brexit will actually look like in practice than they were back then.
 
 
 

November 15, 2018
Matt Hancock made the comments during a five-hour cabinet meeting discussing the Brexit deal negotiated with the EU by Prime Minister Theresa May, according to The Times

The UK's health minister told cabinet members he could not guarantee there would be no deaths if Britain exits the European Union (EU) without a deal, The Times newspaper has reported.
 
Matt Hancock made the comments during a five-hour cabinet meeting discussing the Brexit deal negotiated with the EU by Prime Minister Theresa May, according to the newspaper.
 

November 14, 2018
My pharmacy story: Royal Pharmaceutical Society English Pharmacy Board chair Sandra Gidley

Sandra Gidley has more than two decades of experience as a community pharmacist. 
 
As a former Liberal Democrat MP for Romsey – a post she held between 2000 and 2010 – she is now the chair of the Royal Pharmaceutical Society’s (RPS) English Pharmacy board.
 
She talks to Léa Legraien about her political career, success and why the Government needs to invest more into community pharmacy.
 

November 9, 2018
Diabetes prescriptions cost NHS over £1bn a year, data reveals

NHS England spends over £1bn per year on diabetes prescriptions, data has revealed.
 
A report published yesterday (8 November) by NHS Digital showed that the cost of prescriptions for diabetes has grown by £422m in a decade, reaching more than £1bn in 2017/18.
 

November 8, 2018
Vyxeos is an advanced liposomal formulation that delivers a synergistic molar ratio of daunorubicin and cytarabine

Jazz Pharmaceuticals plc has announced that the National Institute for Health and Care Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending Vyxeos® 44 mg/100 mg powder for concentrate for solution for infusion for routine use on the National Health Service (NHS) in England and Wales.
 

November 8, 2018
UK building ‘refrigeration capacity’ in case of Brexit drug shortages

The UK's health secretary has said that the Government is building extra "refrigeration capacity" in case a no-deal Brexit leaves the country short of certain medicines.
 
Speaking to ITV’s Peston show, Matt Hancock urged patients not to stockpile medicines, and said the Government is working with the pharmaceutical industry to ensure patients are able to obtain necessary medication.
 

November 7, 2018
Olarpip could provide effective treatment for brain tumours, charity reveals

An ovarian cancer drug could be an effective treatment for a difficult-to-treat type of brain tumour, research by a cancer charity has revealed.
 
Olaparib could leak through the blood brain barrier to treat glioblastoma – a condition which many other drugs have failed to treat – according to a study presented at the National Cancer Research Institute’s (NCRI) Cancer Conference in Liverpool on Monday (5 November).
 

November 5, 2018
Easier access to medical cannabis in UK will only benefit a ‘few people’, says NHS England

New legislation making it easier to access medical cannabis will only benefit a few patients, NHS England has said.
 

November 2, 2018
Make vegetarian and vegan alternatives to vaccines, charity urges

There should be vegetarian and vegan alternatives to medicines such as vaccines, a charity has said.
 

October 31, 2018
Researchers make breakthrough on sexually transmitted bacterium

Scientists have discovered the mechanism by which a bacterium adheres to human cells, which is essential for the onset of bacterial infection and disease development.
 
The researchers from the Molecular Biology Institute of Barcelona (IBMB) and the Institute of Biotechnology and Biomedicine (IBB) studied the bacterium mycoplasma genitalium (Mgen) and how it adheres to human cells.
 
They found the mechanism by which it interacts with cells, which the researchers hope will lead to new treatments to fight the infection.
 

October 31, 2018
Scientists discover source for counteracting drug resistance in tumour cells

Researchers have discovered a way of re-sensitising tumour cells that are resistant to cancer drugs.
 
The study, conducted by biologists at the University of California in San Diego, found that a human gene known as Schlafen 11 controls the sensitivity of tumour cells to DNA-damaging agents, which make up most of the widely used cancer drugs.
 

October 29, 2018
Medicines watchdog seizes over £2m counterfeit medicines in UK drugs bust

More than £2m worth of falsified medicines have been seized in the UK in less than three weeks, the Government’s medicines watchdog has revealed.
 
The Medicines and Healthcare products Regulatory Agency (MHRA) said on Wednesday (24 October) that it intercepted one million doses of counterfeit medicines worth over £2m between 9 and 27 October including diazepam, modafinil and dermal fillers.
 

October 26, 2018
Cannabis oil improves symptoms of Crohn’s despite no effect on gut inflammation

Cannabis oil significantly improves symptoms of Crohn’s disease despite having no effect on gut inflammation, according to new research.
 
The study, revealed at UEG Week conference in Vienna this week, found that cannabis produced clinical remission in up to 65% of individuals after eight weeks of treatment. However, it also found that it did this despite having no effect on gut inflammation, contrary to previous medical thinking.
 

October 25, 2018
The European Commission has granted Kigabeq paediatric use marketing authorisation (PUMA) following the recommendation of the Committee for Medicinal Products for Human Use (CHMP).

The European Commission has granted Kigabeq paediatric use marketing authorisation (PUMA) following the recommendation of the Committee for Medicinal Products for Human Use (CHMP).
 
Kigabeq is meant for the treatment of infantile spasms, or West’s syndrome, which is an uncommon and severe form of epilepsy associated with a highly-resistant seizure type and a rapid psychomotor regression. It can also be used to treat partial epilepsy in infants and children from one month to seven years of age.
 

October 25, 2018
Six-week no-deal Brexit drugs stockpile could take over a year to prepare

Stockpiling six weeks worth of medicines after a no-deal Brexit could take over a year due to creating extra storage for drugs that need to be kept in certain conditions, a Government committee has heard.
 
Speaking before the Health and Social Care Committee on Tuesday [23 October], wholesalers’ body the Healthcare Distribution Association (HDA) executive director Martin Sawer explained that building new cold-chain warehouses for medicines that need refrigeration might take more than a year.
 

October 24, 2018
AAC Board recognises evolocumab as a high-potential medicine with full evidence base to support widespread adoption within the NHS

Global biotechnology company Amgen’s Repatha® (evolocumab) has been selected as a Rapid Uptake Product by the Accelerated Access Collaborative (AAC), the Department of Health and Social Care (DHSC) has announced [October 23 2018].
 

October 17, 2018
ImraldiTM approved in the European Union for 13 of the same complex autoimmune conditions as its reference product is now available through the NHS

ImraldiTM is approved in the European Union (EU) for 13 of the same complex autoimmune conditions as its reference product and is now available in the UK via the NHS.
 
Imraldi is approved in Europe for the treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (polyarticular juvenile idiopathic arthritis; enthesitis-related arthritis), axial spondyloarthritis (ankylosing spondylitis (AS) and axial spondyloarthritis with radiographic evidence of AS).
 

October 17, 2018
Pharmacists must implement new validation processes from today (17 October) to prioritise the limited stocks of EpiPen junior 150 microgram (mcg), the Department of Health and Social Care (DHSC) and NHS England have said.

Pharmacists must implement new validation processes from today (17 October) to prioritise the limited stocks of EpiPen junior 150 microgram (mcg), the Department of Health and Social Care (DHSC) and NHS England have said.

October 17, 2018
Pregabalin and gabapentin will be reclassified as class C drugs next year following a rising numbers of deaths linked to the drugs, the Government has said.

Pregabalin and gabapentin will be reclassified as class C drugs next year following a rising numbers of deaths linked to the drugs, the UK Government has said.
 

October 16, 2018
MPs have called on the Government to guarantee the continuity of medicine supplies after Brexit.

MPs have called on the Government to guarantee the continuity of medicine supplies after Brexit.
 
A report published by parliamentary select committee the Public Accounts Committee (PAC) on Friday (12 October) urged the Department of Health and Social Care (DHSC) to share its action plan by December to ensure medicine supplies and address price increasesbefore and after the UK leaves the EU.
 

October 12, 2018
The UK's pharmacy regulator the General Pharmaceutical Council (GPhC) will consult on raising its registration its registration fees for 2019/20 – the first time it has proposed increasing them since 2015 – it has announced.

The UK's pharmacy regulator the General Pharmaceutical Council (GPhC) will consult on raising its registration its registration fees for 2019/20 – the first time it has proposed increasing them since 2015 – it has announced.
The regulator is proposing that pharmacists' fees should raise by £7 to £257, pharmacy technicians' fees should raise by £3 to £121 and pharmacy premises fees should raise by £21 to £262.
The proposed fees are still lower than 2011's fees, the GPhC highlighted.

October 9, 2018
A no-deal Brexit would put a stop to the the falsified medicines directive (FMD) in the UK, the Department of Health and Social Care (DHSC) has said.

A no-deal Brexit would put a stop to the the falsified medicines directive (FMD) in the UK, the Department of Health and Social Care (DHSC) has said.
 

October 2, 2018
Antidepressants have more severe withdrawal symptoms than guidelines suggest, says research

Millions of antidepressant users could experience "severe withdrawals” if they cut down or come off their medication, according to a new review.
 
The UK’s All Party Parliamentary Group (APPG) for Prescribed Drug Dependence reviewed the withdrawal affects of antidepressants across 23 existing studies and found that withdrawals are much more widespread, severe and long lasting than current guidelines suggest.
 

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine